好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Bilateral STN DBS for Parkinson's Disease at 5-Year Follow-Up: A Case Series
Movement Disorders
(-)
149
Authors/Disclosures
No disclosure on file
Anusha Boyanpally, MBBS No disclosure on file
Ebrima Gibbs, Bsc, BMLSc, MSc (University of British Columbia) Dr. Gibbs has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Promis Neurosciences.
Matthew Nardi No disclosure on file
Elisabeth B. Marsh, MD, FAAN (Johns Hopkins School of Medicine) Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Neurological Association. Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. Dr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACTN. The institution of Dr. Marsh has received research support from American Heart Association. The institution of Dr. Marsh has received research support from National Institutes of Health. The institution of Dr. Marsh has received research support from National Institutes of Health.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Neil Cashman, MD (University of British Columbia) Dr. Cashman has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Cashman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IONIS. Dr. Cashman has stock in ProMIS Neurosciences. The institution of Dr. Cashman has received research support from ProMIS Neurosciences. Dr. Cashman has received intellectual property interests from a discovery or technology relating to health care.